In the cancer immunity cycle, the initial activation naïve antitumor CD8+ T cells that recognize potential cancer antigens occurs when dendritic cells that take up tumor cell fragments process and present tumor antigens as MHC-I:peptide complex to naïve CD8+ T cells in tumor draining lymph nodes by a process called antigen cross-presentation (84–89). The gene discussed is CD8A; the disease is cancer.